JAMA Network
About The Study: Nonadherence with the opioid use disorder medication buprenorphine was associated with an increased risk of experiencing an opioid overdose and higher health care expenditures in this study that included 34,000 Medicare patients.
Authors: Jason B. Gibbons, Ph.D., of the Johns Hopkins University Bloomberg School of Public Health in Baltimore, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2022.3118)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
